These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15610865)

  • 1. The association between obesity and the progression of prostate and renal cell carcinoma.
    Amling CL
    Urol Oncol; 2004; 22(6):478-84. PubMed ID: 15610865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity and oncological outcome after radical prostatectomy: impact of prostate-specific antigen-based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases.
    Freedland SJ; Sun L; Kane CJ; Presti JC; Terris MK; Amling CL; Moul JW; Aronson WJ
    BJU Int; 2008 Sep; 102(8):969-74. PubMed ID: 18691175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stronger association between obesity and biochemical progression after radical prostatectomy among men treated in the last 10 years.
    Freedland SJ; Isaacs WB; Mangold LA; Yiu SK; Grubb KA; Partin AW; Epstein JI; Walsh PC; Platz EA
    Clin Cancer Res; 2005 Apr; 11(8):2883-8. PubMed ID: 15837737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal cell carcinoma rates compared with health status and behavior in the United States.
    Colli JL; Busby JE; Amling CL
    Urology; 2009 Feb; 73(2):431-6. PubMed ID: 18701146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ratio of oleic-to-stearic acid in the prostate predicts biochemical failure after radical prostatectomy for localized prostate cancer.
    Kositsawat J; Flanigan RC; Meydani M; Choi YK; Freeman VL
    J Urol; 2007 Dec; 178(6):2391-6; discussion 2396. PubMed ID: 17936811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does body mass index affect preoperative prostate specific antigen velocity or pathological outcomes after radical prostatectomy?
    Loeb S; Yu X; Nadler RB; Roehl KA; Han M; Hawkins SA; Catalona WJ
    J Urol; 2007 Jan; 177(1):102-6; discussion 106. PubMed ID: 17162013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity and survival after radical prostatectomy: A 10-year prospective cohort study.
    Siddiqui SA; Inman BA; Sengupta S; Slezak JM; Bergstralh EJ; Leibovich BC; Zincke H; Blute ML
    Cancer; 2006 Aug; 107(3):521-9. PubMed ID: 16773619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity adversely affects health related quality of life before and after radical retropubic prostatectomy.
    Montgomery JS; Gayed BA; Hollenbeck BK; Daignault S; Sanda MG; Montie JE; Wei JT
    J Urol; 2006 Jul; 176(1):257-61; discussion 261-2. PubMed ID: 16753415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of obesity on prostate cancer recurrence after radical prostatectomy: data from CaPSURE.
    Bassett WW; Cooperberg MR; Sadetsky N; Silva S; DuChane J; Pasta DJ; Chan JM; Anast JW; Carroll PR; Kane CJ
    Urology; 2005 Nov; 66(5):1060-5. PubMed ID: 16286124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity and risk of biochemical progression following radical prostatectomy at a tertiary care referral center.
    Freedland SJ; Grubb KA; Yiu SK; Humphreys EB; Nielsen ME; Mangold LA; Isaacs WB; Partin AW
    J Urol; 2005 Sep; 174(3):919-22. PubMed ID: 16093988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Body mass index and prostate specific antigen as predictors of adverse pathology and biochemical recurrence after prostatectomy.
    Bañez LL; Sun L; Trock BJ; Han M; Partin AW; Aronson WJ; Terris MK; Presti JC; Kane CJ; Amling CL; Moul JW; Freedland SJ
    J Urol; 2009 Aug; 182(2):491-6; discussion 496-8. PubMed ID: 19524974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for renal cell cancer: the multiethnic cohort.
    Setiawan VW; Stram DO; Nomura AM; Kolonel LN; Henderson BE
    Am J Epidemiol; 2007 Oct; 166(8):932-40. PubMed ID: 17656615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tumours of kidneys, urinary bladder and prostate in obesity and diabetes].
    Svacina S
    Vnitr Lek; 2008 May; 54(5):464-7. PubMed ID: 18630627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of obesity on the utility of preoperative prostate-specific antigen velocity to predict for relapse after prostatectomy: a report from the SEARCH database.
    King CR; Freedland SJ; Terris MK; Kane CJ; Amling CL; Aronson WJ; Presti JC
    Urology; 2007 May; 69(5):921-6. PubMed ID: 17482935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are findings from studies of obesity and prostate cancer really in conflict?
    Freedland SJ; Giovannucci E; Platz EA
    Cancer Causes Control; 2006 Feb; 17(1):5-9. PubMed ID: 16411047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity and renal cell carcinoma: epidemiology, underlying mechanisms and management considerations.
    Klinghoffer Z; Yang B; Kapoor A; Pinthus JH
    Expert Rev Anticancer Ther; 2009 Jul; 9(7):975-87. PubMed ID: 19589036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laparoscopic extraperitoneal radical prostatectomy in complex surgical cases.
    Rodriguez AR; Kapoor R; Pow-Sang JM
    J Urol; 2007 May; 177(5):1765-70. PubMed ID: 17437812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laparoscopic radical prostatectomy and body mass index: an assessment of 151 sequential cases.
    Brown JA; Rodin DM; Lee B; Dahl DM
    J Urol; 2005 Feb; 173(2):442-5. PubMed ID: 15643198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity and prostate cancer: epidemiology and clinical implications.
    Buschemeyer WC; Freedland SJ
    Eur Urol; 2007 Aug; 52(2):331-43. PubMed ID: 17507151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current state of urological cryosurgery: prostate and kidney.
    Levy D; Avallone A; Jones JS
    BJU Int; 2010 Mar; 105(5):590-600. PubMed ID: 20149203
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.